GSK’s Tesaro Sues AnaptysBio, Seeks to Terminate Current Jemperli Contract

AnaptysBio has separately alleged that GSK subsidiary Tesaro breached “certain requirements” under their 2014 license agreement involving a program that would become GSK’s Jemperli.